TITLE

Metabolic Syndrome and Cardiovascular Mortality in Older Type 2 Diabetic Patients: A Longitudinal Study

AUTHOR(S)
Monami, Matteo; Lamanna, Caterina; Balzi, Daniela; Bartalucci, Francesca; Melani, Cecilia; Masotti, Giulio; Marchionni, Niccolô; Mannucci, Edoardo
PUB. DATE
June 2008
SOURCE
Journals of Gerontology Series A: Biological Sciences & Medical ;Jun2008, Vol. 63 Issue 6, p646
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Although age does not seem to modify the association of the metabolic syndrome (MS) with cardiovascular risk in middle-aged individuals, no comparison of risks associated with MS between old and middle-aged persons has been reported so far. Methods. An observational study was performed on a consecutive series of 1716 type 2 diabetic outpatients (age range: 28-96 years). The diagnosis of MS was made following either the National Cholesterol Education Program-Adult Treatment Panel (NCEP-ATPITT) or the International Diabetes Federation (IDF) criteria. Results. The difference in cardiovascular mortality between patients with and without MS was significant up to the age of 70 years. After adjusting for age and sex, hazard ratios of MS for cardiovascular mortality were 3.03 (95% confidence interval, 1.45-6.29), 1.56 (0.91-2.68), and 1.17 (0.42-3.22) in patients ≤70, 71-80, and >80 years old, respectively. Conclusions. MS is associated with increased cardiovascular risk in middle-aged type 2 diabetic patients, and the clinical utility of this category in older diabetic individuals is questionable.
ACCESSION #
32847097

 

Related Articles

  • Renal Dysfunction, Metabolic Syndrome and Cardiovascular Disease Mortality. Martins, David; Ani, Chizobam; Pan, Deyu; Ogunyemi, Omolola; Norris, Keith // Journal of Nutrition & Metabolism;2010, p1 

    Background. Renal disease is commonly described as a complication of metabolic syndrome (MetS) but some recent studies suggest that Chronic Kidney disease (CKD) may actually antecede MetS. Few studies have explored the predictive utility of co-clustering CKD with MetS for cardiovascular disease...

  • Age- and gender-specific population attributable risks of metabolic disorders on all-cause and cardiovascular mortality in Taiwan.  // BMC Public Health;2012, Vol. 12 Issue 1, p111 

    The article discusses a study conducted to assess the age and gender effects of metabolic syndrome (MetS) and metabolic disorders on all-cause and cardiovascular disease (CVD)-related mortality within an 8-year follow-up period in Taiwan. It has been informed that the study results show...

  • The effects of ProAlgaZyme novel algae infusion on metabolic syndrome and markers of cardiovascular health. Oben, Julius; Enonchong, Ebangha; Kuate, Dieudonne; Mbanya, Dora; Thomas, Tiffany C.; Hildreth, DeWall J.; Ingolia, Thomas D.; Tempesta, Michael S. // Lipids in Health & Disease;2007, Vol. 6, p20 

    Background: Metabolic Syndrome, or Syndrome X, is characterized by a set of metabolic and lipid imbalances that greatly increases the risk of developing diabetes and cardiovascular disease. The syndrome is highly prevalent in the United States and worldwide, and treatments are in high demand....

  • Metabolic syndrome in menopausal transition: Isfahan Healthy Heart Program, a population based study. Heidari, Ramin; Sadeghi, Masoumeh; Talaei, Mohammad; Rabiei, Katayoun; Mohammadifard, Noushin; Sarrafzadegan, Nizal // Diabetology & Metabolic Syndrome;2010, Vol. 2 Issue 1, p1 

    Introduction: There is a remarkable increase in cardiovascular disease after menopause. On the other hand, metabolic syndrome as a collection of risk factors has a known effect on cardiovascular diseases. Hormone changes are considered as one of the main relevant factor regarding cardiovascular...

  • DETECTING AND MANAGING METABOLIC SYNDROME: A FEASIBILITY STUDY IN A GENERAL MEDICINE CLINIC. De la Rosa, Alexandra; Tahsin, Bettina; Sanghani, Roshani; Pikelny, Iry; Fogelfeld, Leon; Stroger Jr., John H. // Ethnicity & Disease;Spring2008 Supplement1, Vol. 18, pS1:6 

    Metabolic syndrome is a constellation of risk factors associated with increased cardiovascular and diabetes risk. Clinical research indicates that lifestyle changes can dramatically modify and even reverse all factors of metabolic syndrome. This study examines the feasibility of lifestyle...

  • The relation of metabolic syndrome according to five definitions to cardiovascular risk factors - a population-based study. Cheng-Chieh Lin; Chiu-Shong Liu; Chia-Ing Li; Wen-Yuan Lin; Ming-May Lai; Tsann Lin; Pei-Chia Chang; Yih-Dar Lee; Ching-Chu Chen; Chih-Hsueh Lin; Chuan-Wei Yang; Chih-Yi Hsiao; Chen, Walter; Tsai-Chung Li // BMC Public Health;2009, Vol. 9 Issue 1, p484 

    Background: Although National Cholesterol Education Program (NCEP), International Diabetes Federation (IDF), American Heart Association and National Heart, Lung and Blood Institute (AHA/NHLBI), World Health Organization (WHO), and the European Group for the Study of Insulin Resistance (EGIR)...

  • Metabolic Syndrome as a Risk Factor for Cardiovascular Disease, Mortality, and Progression of Diabetic Nephropathy in Type 1 Diabetes. Thorn, Lena M.; Forsblom, Carol; Wadén, Johan; Saraheimo, Markku; Tolonen, Nina; Hietala, Kustaa; Groop, Per-Henrik // Diabetes Care;May2009, Vol. 32 Issue 5, p950 

    OBJECTIVE -- To assess the predictive value of the metabolic syndrome in patients with type 1 diabetes. RESEARCH DESIGN AND METHODS -- Patients were from the prospective Finnish Diabetic Nephropathy (FinnDiane) Study (n = 3,783): mean age 37 ± 12 years and diabetes duration 23 ± 12 years....

  • The Science of Lipidology Impacts Underwriting and Improves Mortality. Gleeson, Robert // Journal of Insurance Medicine;2009, Vol. 41 Issue 3, p197 

    Substantial change in how we think about lipids and atherosclerosis is on the afoot. Discoveries in lipidology are changing the relative importance of commonly used lipid markers, and indentifying new lipid markers for premature disease, new targets for treatment, and new treatment regimens....

  • LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN PATIENTS WITH METABOLIC SYNDROME. Penjašković, Davor; Sakač, Dejan; Dejanović, Jovanka; Zec, Radovan; Zec-Petković, Nada; Stojšić-Milosavljević, Anastazija // Medicinski Pregled / Medical Review;Jan/Feb2012, Vol. 65 Issue 1/2, p18 

    Metabolic syndrome (MetS), which is a cluster of medical disorders, is common and it is associated with increased cardiovascular morbidity and mortality. The aim of this study was to evaluate the relationship between characteristics of metabolic syndrome and the grade of diastolic dysfunction....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics